APPLIED MOLECULAR TRANS INC's ticker is AMTI and the CUSIP is 03824M109. A total of 82 filers reported holding APPLIED MOLECULAR TRANS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71,656 | -45.0% | 456,409 | -9.6% | 0.00% | – |
| Q2 2023 | $130,247 | -30.8% | 504,835 | -14.2% | 0.00% | – |
| Q1 2023 | $188,306 | -24.1% | 588,457 | -0.3% | 0.00% | – |
| Q4 2022 | $247,979 | -68.2% | 590,425 | -26.3% | 0.00% | – |
| Q3 2022 | $780,000 | -72.1% | 800,765 | -16.7% | 0.00% | – |
| Q2 2022 | $2,798,000 | -81.9% | 961,466 | -53.2% | 0.00% | – |
| Q1 2022 | $15,443,000 | -43.0% | 2,053,572 | +5.9% | 0.00% | -100.0% |
| Q4 2021 | $27,115,000 | -44.1% | 1,939,444 | +3.4% | 0.00% | 0.0% |
| Q3 2021 | $48,515,000 | -40.0% | 1,875,410 | +6.0% | 0.00% | -50.0% |
| Q2 2021 | $80,924,000 | +0.7% | 1,769,231 | -3.1% | 0.00% | 0.0% |
| Q1 2021 | $80,349,000 | +92.6% | 1,825,684 | +34.7% | 0.00% | +100.0% |
| Q4 2020 | $41,716,000 | +36.0% | 1,355,746 | +40.6% | 0.00% | 0.0% |
| Q3 2020 | $30,672,000 | +345.1% | 963,915 | +251.6% | 0.00% | – |
| Q2 2020 | $6,891,000 | – | 274,147 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund V Management, LLC | 3,611,615 | $567,024 | 70.62% |
| Founders Fund VI Management, LLC | 826,607 | $129,777 | 0.98% |
| EPIQ Capital Group, LLC | 8,689,075 | $1,364,185 | 0.71% |
| GEODE CAPITAL MANAGEMENT, LLC | 139,808 | $21,949 | 0.00% |
| OSAIC HOLDINGS, INC. | 500 | $78 | 0.00% |
| STATE STREET CORP | 55,055 | $8,644 | 0.00% |
| NEW YORK STATE COMMON RETIREMENT FUND | 650 | $0 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 49,958 | $7,843 | 0.00% |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 66,207 | $10,395 | 0.00% |
| Qube Research & Technologies Ltd | 2,104 | $330 | 0.00% |